SCHEMBL3045682

SCHEMBL3045682

O=C(Cc1cccc2ccccc12)Oc1cccs1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 6/20 0.60
▸ LMNA P02545 4/20 0.57
▸ ALDH1A1 P00352 3/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ POLB P06746 1/20 0.57
▸ HPGD P15428 1/20 0.57
▸ BLM P54132 1/20 0.57
▸ TDP1 Q9NUW8 2/20 0.57
▸ MAPT P10636 4/20 0.55
▸ THRB P10828 1/20 0.55
▸ SIRT5 Q9NXA8 1/20 0.54
▸ NR2F2 P24468 1/20 0.50
▸ HTT P42858 2/20 0.48
▸ GAA P10253 1/20 0.48
▸ MAPK8 P45983 2/20 0.48
▸ PKM P14618 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3053077 0.78 L3MBTL1 (0.61) L3MBTL1LMNAALDH1A1MEN1KMT2A
SCHEMBL5888866 0.77 L3MBTL1 (0.78) L3MBTL1LMNAALDH1A1MEN1KMT2A
SCHEMBL3052007 0.77 L3MBTL1 (0.78) L3MBTL1LMNAALDH1A1MEN1KMT2A
SCHEMBL3039024 0.77 L3MBTL1 (0.60) L3MBTL1LMNAALDH1A1MEN1KMT2A
SCHEMBL590845 0.76 TDP1 (0.67) L3MBTL1LMNAALDH1A1MEN1KMT2A
SCHEMBL8181001 0.75 SMN1; SMN2 (0.50) L3MBTL1ALDH1A1MEN1KMT2ASMN1; SMN2
Ammonia Solution, Strong SCHEMBL21246670 0.75 TDP1 (0.65) L3MBTL1LMNAALDH1A1MEN1KMT2A
SCHEMBL28818018 0.75 L3MBTL1 (0.65) L3MBTL1LMNAALDH1A1MEN1KMT2A
SCHEMBL17583598 0.75 MAPT (0.62) L3MBTL1LMNAALDH1A1MEN1KMT2A
SCHEMBL2550650 0.73 NPC1 (0.54) L3MBTL1LMNAALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8647878-B2 Highly refractive immersion liquids and their use CARL ZEISS AG (DE) 2014-02-11 — — US disclosed
US-20100212547-A1 Highly Refractive Immersion Liquids And Their Use CARL ZEISS AG (DE) 2010-08-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100212547-A1 Highly Refractive Immersion Liquids And Their Use NR4A3, NR2E3, NR4A1 L3MBTL1 2996/4885LMNA 2361/4885ALDH1A1 3757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback